Risk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections in central Taiwan

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Chen, Chang Hua ^a,b   Huang, Chieh Chen ^c  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Bloodstream infections; Class 1 integron; Enterobacter cloacae; Extended Spectrum Lactamase; Mortality; Risk factors

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; FLOMOXEF; GENTAMICIN; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; ANTIINFECTIVE AGENT; BETA LACTAMASE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BLOODSTREAM INFECTION; CHILD; CLONE; CONTROLLED STUDY; DISEASE SEVERITY; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTER CLOACAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL INFECTION; HUMAN; INFANT; INTEGRON; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PULSED FIELD GEL ELECTROPHORESIS; RISK ASSESSMENT; TAIWAN; VENTILATOR; BACTEREMIA; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAMASES; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 84883548732     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-417     Document Type: Article

References (21)

1. Farmer JJ. Enterobacteriaceae: introduction and identification. Manual of clinical microbiology 1999, 442-458. Washington, D.C: American Society for Microbiology, Murray PR, Baron EJ, Tenover FC, Yolken RH, 7.
2. Jalaluddin S, Devaster JM, Scheen R, Gerard M, Butzler JP. Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital. J Clin Microbiol 1998, 36:1846-1852. 104939, 9650923.
3. Ma L, Chang FY, Fung CP, Chen TL, Lin JC, Lu PL, Huang LY, Chang JC, Siu LK. Variety of TEM-, SHV-, and CTX-M-type beta-lactamases present in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae from Taiwan. Microb Drug Resist 2005, 11:31-39. 10.1089/mdr.2005.11.31, 15770092.
4. Liu CP, Wang NY, Lee CM, Weng LC, Tseng HK, Liu CW, Chiang CS, Huang FY. Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre. J Hosp Infect 2004, 58:63-77. 10.1016/j.jhin.2004.04.019, 15350716.
5. Patricia A. Bradford. extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 2001, 14:933-995. 10.1128/CMR.14.4.933-951.2001, 89009, 11585791.
6. Bennett PM. Integrons and gene cassette: a genetic construction kit for bacteria. J Antimicrob Chemother 1999, 43:1-4.
7. Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000, 44:891-897. 10.1128/AAC.44.4.891-897.2000, 89788, 10722487.
8. Girlich D, Poirel L, Leelaporn A, Karim A, Tribuddharat C, Fennewald M, Girlich D. Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 2001, 39:175-182. 10.1128/JCM.39.1.175-182.2001, 87698, 11136767.
9. Jiang X, Ni Y, Jiang Y, Yuan F, Han L, Li M, Liu H, Yang L, Lu Y. Outbreak of infection caused by Enterobacter cloacae producing the novel VEB-3 beta-lactamase in China. J Clin Microbiol 2005, 43:826-831. 10.1128/JCM.43.2.826-831.2005, 548041, 15695687.
10. McCabe W, Jackson CG. Gram negative bacteremia I. etiology and ecology. Arch Intern Med 1962, 36:1020-1027.
11. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332. 10.1016/j.ajic.2008.03.002, 18538699.
12. Clinical and Laboratory Standards Institute (CLSI) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard 2012, USA: CLSI: Document M7-A9. Wayne, PA, 6, Clinical and Laboratory Standards Institute (CLSI).
13. Sanders CC, Barry AL, Washington JA, Shubert C, Moland ES, Traczewski MM, Knapp C, Mulder R. Detection of extended-spectrum-β-lactamase-producing members of the family Enterobacteriaceae with the Vitek ESBL test. J Clin Microbiol 1996, 34:2997-3001. 229448, 8940437.
14. Koeleman JG, Stoof J, Van Der Bijl MW, Vandenbroucke-Grauls CM, Savelkoul PH. Identification of epidemic strains of acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001, 39:8-13. 10.1128/JCM.39.1.8-13.2001, 87671, 11136740.
15. Fernández A, Pereira MJ, Suárez JM, Poza M, Treviño M, Villalón P, Sáez-Nieto JA, Regueiro BJ, Villanueva R, Bou G. Emergence in Spain of a multidrug-resistant Enterobacter cloacae clinical isolate producing SFO-1 extended-spectrum β-lactamase. J Clin Microbiol 2011, 49:822-828. 10.1128/JCM.01872-10, 3067750, 21227991.
16. Turnover FC. Plasmid fingerprinting: a tool for bacterial strain identification and surveillance of nosocomial and community-acquired infections. Clin Lab Med 1985, 5:413-436.
17. Ahmad M, Urban C, Mariano N, Bradford PA, Calcagni E, Projan SJ, Bush K, Rahal JJ. Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae. Clin Infect Dis 1999, 29:352-355. 10.1086/520214, 10476741.
18. Severino P, Magalhães VD. Integrons as tools for epidemiological studies. Clin Microbiol Infect 2004, 10:156-162. 10.1111/j.1469-0691.2004.00769.x, 14759241.
19. Richard VG. Molecular epidemiology of nosocomial infection: analysis of chromosomal restriction fragment patterns by pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol 1993, 14:595-600. 10.1086/646645, 7901269.
20. Ho PL, Shek RH, Chow KH, Duan RS, Mak GC, Lai EL, Yam WC, Tsang KW, Lai WM. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J Antimicrob Chemother 2005, 55:326-332. 10.1093/jac/dki010, 15681579.
21. Freeman JT, McBride SJ, Nisbet MS, Gamble GD, Williamson DA, Taylor SL, Holland DJ. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes. Int J Infect Dis 2012, 16:e371-e374.